MICROVASCULAR ALTERATIONS IN SYSTEMIC CONNECTIVE TISSUE DISEASES
Main researcher
: BRUMEN, VLATKA (119715) Assistants
BOGADI-ŠARE, ANA (113110)
TROŠIĆ, IVANČICA (50540)
ČOROVIĆ, NAIMA (82953)
MIHELČIĆ-ČIKEŠ, NADA (30784)
SENTIĆ, MIRNA (203891)
BULJEVIĆ, BRUNO (203876)
MILEUSNIĆ, LJILJANA (203880)
ANIĆ, BRANIMIR (140514)
HORVAT, ĐURĐA (16303)
Type of research: basic Duration from: 11/10/93. to 12/31/94. Papers on project (total): 19
Papers on project quoted in Current Contents: 3
Institution name: Institut za medicinska istraživanja i medicinu rada, Zagreb (22) Department/Institute: Occupational Medicine Department IMR & Division of Clinical Immunology & Rheumatology, Medicine Department, Medical College University of Zagreb Address: Jordanovac 104, Kišpatićeva 12 City: 10000 - Zagreb, Croatia
Communication
Phone: 385 (0)1-434-188, 223-180
Fax: 385 (0)1-274-572, 223-180
Summary: The research is aimed at investigating of microcircular
alterations in systemic connective tissue diseases on the basis of
extensive clinical and corresponding experimental studies. Findings
obtained by the peripheral blood flow survey, clinical and laboratory
analysis, pathohistology and cytogenetic methods will be mutually compared
in order to establish a possible correlation among those. The primary goal
of the study is an attempt to establish our own criteria for the
interpretation of microvascular impairments in systemic connective tissue
diseases based upon the evaluation of results obtained among statistically
relevant selected population group and a matched number of healthy
controls, through quantification of basically semiquantitative methods. A
study designed in this way is aimed not only at claryfing the unresolved
problem of systemic connective tissue diseases' ethiopathogenesis, but
also at improving their early diagnosis and therapy in everyday medical
practice.
Research goals: Due to the current belief that microvascular
impairments underlie the development of SCTD, those changes will be the
subject of extensive clinical and corresponding experimental studies in a
selected population group and matched healthy controls. Biological study
will necessarily be limited to the observation of secondary effects of
potent vasoactive substances applied onto the experimental animal, and of
the effects of drugs commonly used in the therapy of the SCTD. The drug
effect will be evaluated from the aspect of primary microvessel changes,
and from the aspect of their genotoxicity. Microvascular changes will be
detected stereomicroscopically in vivo, and pathohistologically, upon
sacrifizing the experimental animal. Genotoxic effect will be verified by
the conventional structural chromosomal aberration analysis and by the
sister chromatid exchange method. Microvessel changes in the selected
population groups will be determined by a serial application of
capillaroscopy, dermothermometry and photoplethysmography in each
examinee. These findings will be compared with those obtained by clinical
and laboratory analyses, mutagenetic tests and eponichial biopsy. The
study is aimed not only at clarifying the scientific problem of the SCTD
ethiopathogenesis, but also at improving their early diagnosis and
therapy.
COOPERATION - PROJECTS
Name of project
: 3-01-402 Psihosocioepidemiološka istraživanja u
sistemskim bolestima veziva Name of institution: Medicinski fakultet Sveučilišta u Zagrebu City: 10000 - Zagreb, Croatia
COOPERATION - INSTITUTIONS
Name of institution
: Medicinski fakultet Sveučilišta u Zagrebu,
KBC Type of institution: University/Faculty Type of cooperation: Joint project City: 10000 - Zagreb, Croatia Other information about the project.